IL91581A - Methods for preparing optically active captopril and its analogues - Google Patents

Methods for preparing optically active captopril and its analogues

Info

Publication number
IL91581A
IL91581A IL91581A IL9158189A IL91581A IL 91581 A IL91581 A IL 91581A IL 91581 A IL91581 A IL 91581A IL 9158189 A IL9158189 A IL 9158189A IL 91581 A IL91581 A IL 91581A
Authority
IL
Israel
Prior art keywords
captopril
analogues
methods
optically active
preparing optically
Prior art date
Application number
IL91581A
Other languages
English (en)
Other versions
IL91581A0 (en
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of IL91581A0 publication Critical patent/IL91581A0/xx
Publication of IL91581A publication Critical patent/IL91581A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL91581A 1988-09-13 1989-09-08 Methods for preparing optically active captopril and its analogues IL91581A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24420388A 1988-09-13 1988-09-13

Publications (2)

Publication Number Publication Date
IL91581A0 IL91581A0 (en) 1990-04-29
IL91581A true IL91581A (en) 1993-07-08

Family

ID=22921794

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91581A IL91581A (en) 1988-09-13 1989-09-08 Methods for preparing optically active captopril and its analogues

Country Status (5)

Country Link
EP (1) EP0434743A4 (xx)
JP (1) JPH04500673A (xx)
AU (1) AU4304789A (xx)
IL (1) IL91581A (xx)
WO (1) WO1990002732A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208954B (en) * 1990-09-21 1994-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing 1-(3-mercapto-(2s)-methyl-1-oxo-propyl)-l-prolyn
US5026873A (en) * 1989-11-06 1991-06-25 E. R. Squibb & Sons, Inc. Process for direct isolation of captopril

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) * 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4046889A (en) * 1976-02-13 1977-09-06 E. R. Squibb & Sons, Inc. Azetidine-2-carboxylic acid derivatives
IT7851510A0 (it) * 1977-10-28 1978-10-16 Sandoz Ag Ammidi di amminoacidi ciclici loro preparazione e loro applicazione quali medicamenti
US4154934A (en) * 1978-08-11 1979-05-15 E. R. Squibb & Sons, Inc. Mercaptoacylamino derivatives of heterocyclic carboxylic acids
US4297282A (en) * 1979-03-02 1981-10-27 Sumitomo Chemical Company, Limited Resolution of mercaptopropionic acids
US4288368A (en) * 1979-07-30 1981-09-08 E. R. Squibb & Sons, Inc. Dithioacylproline derivatives
HU184082B (en) * 1979-12-29 1984-06-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing 1-3-/3mercapto-/2s/-methyl-propinyl/-pyrrolidine-/2s/-carboxylic acid
IE50839B1 (en) * 1980-02-26 1986-07-23 Wyeth John & Brother Ltd Novel processes for preparing proline derivatives and analogous compounds

Also Published As

Publication number Publication date
EP0434743A4 (en) 1991-09-25
IL91581A0 (en) 1990-04-29
AU4304789A (en) 1990-04-02
EP0434743A1 (en) 1991-07-03
JPH04500673A (ja) 1992-02-06
WO1990002732A1 (en) 1990-03-22

Similar Documents

Publication Publication Date Title
ZA893508B (en) Insulin analogues
GB2242631B (en) Needle
GB8704810D0 (en) Stable ophthalmic preparations
EP0355247A3 (en) Compressed-molded preparations
EP0391997A4 (en) Vaccine
KR0152645B1 (en) Optically active diester
HU895714D0 (en) Syringe for single use
GB8911145D0 (en) Goggles
GB8822157D0 (en) Tissue modification
IL91581A (en) Methods for preparing optically active captopril and its analogues
DK614589A (da) Imidazolholdige peptider samt fremgangsmaade til fremstilling deraf
GB2225237B (en) Ophthalmic preparations
EP0336619A3 (en) Optically active pyridylethanol derivatives
GB2204579B (en) Optically active oxo-isoindolinyl derivatives
EP0257448A3 (en) Optically active cyclopropanecarboxamides
EP0408332A3 (en) Natural fermentation agent
GB8819836D0 (en) Vaccine
IE883821L (en) Preparing optically active cyanohydrins
ZA899501B (en) Human insulin analogues
CS857388A1 (en) Method of optically active cis-cycloeutanone preparation
AU106459S (en) Stump support
IE880607L (en) Skin substitutes
IE894150L (en) Human insulin analogues
IE883611L (en) Griseolic acid monoesters
IE880831L (en) Vaccines

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
RH1 Patent not in force